Roger M. Pinder

975 total citations
37 papers, 528 citations indexed

About

Roger M. Pinder is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Roger M. Pinder has authored 37 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Cellular and Molecular Neuroscience and 6 papers in Molecular Biology. Recurrent topics in Roger M. Pinder's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Treatment of Major Depression (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Roger M. Pinder is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Treatment of Major Depression (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Roger M. Pinder collaborates with scholars based in United Kingdom, United States and Netherlands. Roger M. Pinder's co-authors include Joop H. Wieringa, Leslie L. Iversen, Richard Miller, Alan S. Horn, Robert J. Naylor, B. Costall, Alfred Burger, Wanda Hinshaw, David M. Green and C.L.E. Broekkamp and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Roger M. Pinder

34 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger M. Pinder United Kingdom	12	231	194	104	94	61	37	528
Izyaslav P. Lapin Russia	11	159 0.7×	121 0.6×	46 0.4×	62 0.7×	53 0.9×	16	438
J. Buus Lassen Denmark	13	272 1.2×	188 1.0×	142 1.4×	40 0.4×	89 1.5×	28	517
F. E. SOROKO United States	11	202 0.9×	175 0.9×	67 0.6×	204 2.2×	85 1.4×	19	579
M.M. Airaksinen Finland	15	274 1.2×	381 2.0×	102 1.0×	146 1.6×	40 0.7×	56	803
M.B. Assié France	8	281 1.2×	170 0.9×	115 1.1×	42 0.4×	103 1.7×	16	452
Marshall B. Wallach United States	15	269 1.2×	177 0.9×	176 1.7×	134 1.4×	52 0.9×	27	697
B. T. HO United States	16	260 1.1×	222 1.1×	110 1.1×	54 0.6×	88 1.4×	33	689
Mark R. Szewczak United States	10	320 1.4×	267 1.4×	129 1.2×	135 1.4×	89 1.5×	13	662
Lennart Florvall Sweden	12	253 1.1×	255 1.3×	62 0.6×	115 1.2×	107 1.8×	27	571
O. Tofanetti Italy	14	146 0.6×	139 0.7×	113 1.1×	87 0.9×	73 1.2×	35	749

Countries citing papers authored by Roger M. Pinder

Since Specialization

Citations

This map shows the geographic impact of Roger M. Pinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger M. Pinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger M. Pinder more than expected).

Fields of papers citing papers by Roger M. Pinder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger M. Pinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger M. Pinder. The network helps show where Roger M. Pinder may publish in the future.

Co-authorship network of co-authors of Roger M. Pinder

This figure shows the co-authorship network connecting the top 25 collaborators of Roger M. Pinder. A scholar is included among the top collaborators of Roger M. Pinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger M. Pinder. Roger M. Pinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pinder, Roger M. & Max Fink. (2015). Mianserin. PubMed. 18. 70–101. 1 indexed citations

Pinder, Roger M.. (2011). Alcohol-attributable cancer: fact or fiction?. 21–21. 2 indexed citations

Pinder, Roger M.. (2008). Is Alzheimer's a preventable disease?. Annals of General Psychiatry. 7(S1). 3 indexed citations

Pinder, Roger M.. (2007). Treatment of generalized anxiety disorder. Neuropsychiatric Disease and Treatment. 3(2). 183–184. 10 indexed citations

Pinder, Roger M.. (2007). Pathological gambling and dopamine agonists: A phenotype?. Neuropsychiatric Disease and Treatment. 3(1). 1–2. 6 indexed citations

Pinder, Roger M.. (2006). Restless legs is a medical disorder and can be treated. Neuropsychiatric Disease and Treatment. 2(4). 391–392. 1 indexed citations

Pinder, Roger M.. (2006). Migraine ? a suitable case for treatment?. Neuropsychiatric Disease and Treatment. 2(3). 245–246. 3 indexed citations

Pinder, Roger M.. (2005). Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?. Neuropsychiatric Disease and Treatment. 1(1). 3–7. 8 indexed citations

Pinder, Roger M.. (2004). Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?. Acta Neuropsychiatrica. 16(4). 185–189. 1 indexed citations

10.

Roose, Steven P. & Roger M. Pinder. (2003). Chairmen’s Introduction. European Neuropsychopharmacology. 13. 67–68. 1 indexed citations

11.

Montgomery, Stuart, Per Bech, Pierre Blier, et al.. (2002). Selecting Methodologies for the Evaluation of Differences in Time to Response Between Antidepressants. The Journal of Clinical Psychiatry. 63(8). 694–699. 33 indexed citations

12.

Pinder, Roger M.. (2001). Introduction. Depression: The Relevance of the Time Factor. The Journal of Clinical Psychiatry. 62. 5–7. 2 indexed citations

13.

Pinder, Roger M.. (2001). On the feasibility of designing new antidepressants. Human Psychopharmacology Clinical and Experimental. 16(1). 53–59. 7 indexed citations

14.

Berendsen, Hemmie H.G., C.L.E. Broekkamp, & Roger M. Pinder. (1998). Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats. Psychopharmacology. 135(3). 284–289. 15 indexed citations

15.

Pinder, Roger M. & Joop H. Wieringa. (1993). Third‐generation antidepressants. Medicinal Research Reviews. 13(3). 259–325. 80 indexed citations

16.

Pinder, Roger M.. (1991). Mianserin: Pharmacological and clinical correlates. Nordisk Psykiatrisk Tidsskrift. 45(sup24). 13–26. 13 indexed citations

17.

Pinder, Roger M.. (1983). Mianserin pharmacokinetics—a reply. British Journal of Clinical Pharmacology. 16(2). 202–203. 1 indexed citations

18.

Costall, B., Robert J. Naylor, & Roger M. Pinder. (1976). Hyperactivity induced by tetrahydroisoquinoline derivatives injected into the nucleus accumbens. European Journal of Pharmacology. 39(1). 153–160. 23 indexed citations

19.

Pinder, Roger M., et al.. (1976). Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-l,2,3,4-tetrahydronaphthalene. Nature. 259(5544). 584–587. 34 indexed citations

20.

Pinder, Roger M., et al.. (1969). 2-Amino-3-phenyl-1,1,1-trifluoropropanes. Fluorine analogs of amphetamines. Journal of Medicinal Chemistry. 12(2). 322–324. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact